US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

Executive summary

R. Andres Floto, Kenneth N. Olivier, Lisa Saiman, Charles L. Daley, Jean Louis Herrmann, Jerry A. Nick, Peadar G. Noone, Diana Bilton, Paul Corris, Ronald L. Gibson, Sarah E. Hempstead, Karsten Koetz, Kathryn A. Sabadosa, Isabelle Sermet-Gaudelus, Alan R. Smyth, Jakko Van Ingen, Richard J. Wallace, Kevin L. Winthrop, Bruce Marshall, Charles S. Haworth

Research output: Contribution to journalArticle

Abstract

Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease, such as cystic fibrosis (CF). Pulmonary disease (PD) caused by NTM has emerged as a major threat to the health of individuals with CF, but remains difficult to diagnose and problematic to treat. In response to this challenge, the US Cystic Fibrosis Foundation (CFF) and the European Cystic Fibrosis Society (ECFS) convened a panel of 19 experts to develop consensus recommendations for the screening, investigation, diagnosis and management of NTM-PD in individuals with CF. PICO ( population, intervention, comparison, outcome) methodology and systematic literature reviews were employed to inform draft recommendations, which were then modified to achieve consensus and subsequently circulated for public consultation within the USA and European CF communities. We have thus generated a series of pragmatic, evidence-based recommendations as an initial step in optimising management for this challenging condition.

Original languageEnglish (US)
Pages (from-to)88-90
Number of pages3
JournalThorax
Volume71
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Mycobacterium
Cystic Fibrosis
Lung Diseases
Referral and Consultation
Lung
Health
Infection
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis : Executive summary. / Floto, R. Andres; Olivier, Kenneth N.; Saiman, Lisa; Daley, Charles L.; Herrmann, Jean Louis; Nick, Jerry A.; Noone, Peadar G.; Bilton, Diana; Corris, Paul; Gibson, Ronald L.; Hempstead, Sarah E.; Koetz, Karsten; Sabadosa, Kathryn A.; Sermet-Gaudelus, Isabelle; Smyth, Alan R.; Van Ingen, Jakko; Wallace, Richard J.; Winthrop, Kevin L.; Marshall, Bruce; Haworth, Charles S.

In: Thorax, Vol. 71, No. 1, 01.01.2016, p. 88-90.

Research output: Contribution to journalArticle

Floto, RA, Olivier, KN, Saiman, L, Daley, CL, Herrmann, JL, Nick, JA, Noone, PG, Bilton, D, Corris, P, Gibson, RL, Hempstead, SE, Koetz, K, Sabadosa, KA, Sermet-Gaudelus, I, Smyth, AR, Van Ingen, J, Wallace, RJ, Winthrop, KL, Marshall, B & Haworth, CS 2016, 'US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: Executive summary', Thorax, vol. 71, no. 1, pp. 88-90. https://doi.org/10.1136/thoraxjnl-2015-207983
Floto, R. Andres ; Olivier, Kenneth N. ; Saiman, Lisa ; Daley, Charles L. ; Herrmann, Jean Louis ; Nick, Jerry A. ; Noone, Peadar G. ; Bilton, Diana ; Corris, Paul ; Gibson, Ronald L. ; Hempstead, Sarah E. ; Koetz, Karsten ; Sabadosa, Kathryn A. ; Sermet-Gaudelus, Isabelle ; Smyth, Alan R. ; Van Ingen, Jakko ; Wallace, Richard J. ; Winthrop, Kevin L. ; Marshall, Bruce ; Haworth, Charles S. / US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis : Executive summary. In: Thorax. 2016 ; Vol. 71, No. 1. pp. 88-90.
@article{bc651f07e9b440b6a438ef852b91c146,
title = "US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: Executive summary",
abstract = "Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease, such as cystic fibrosis (CF). Pulmonary disease (PD) caused by NTM has emerged as a major threat to the health of individuals with CF, but remains difficult to diagnose and problematic to treat. In response to this challenge, the US Cystic Fibrosis Foundation (CFF) and the European Cystic Fibrosis Society (ECFS) convened a panel of 19 experts to develop consensus recommendations for the screening, investigation, diagnosis and management of NTM-PD in individuals with CF. PICO ( population, intervention, comparison, outcome) methodology and systematic literature reviews were employed to inform draft recommendations, which were then modified to achieve consensus and subsequently circulated for public consultation within the USA and European CF communities. We have thus generated a series of pragmatic, evidence-based recommendations as an initial step in optimising management for this challenging condition.",
author = "Floto, {R. Andres} and Olivier, {Kenneth N.} and Lisa Saiman and Daley, {Charles L.} and Herrmann, {Jean Louis} and Nick, {Jerry A.} and Noone, {Peadar G.} and Diana Bilton and Paul Corris and Gibson, {Ronald L.} and Hempstead, {Sarah E.} and Karsten Koetz and Sabadosa, {Kathryn A.} and Isabelle Sermet-Gaudelus and Smyth, {Alan R.} and {Van Ingen}, Jakko and Wallace, {Richard J.} and Winthrop, {Kevin L.} and Bruce Marshall and Haworth, {Charles S.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1136/thoraxjnl-2015-207983",
language = "English (US)",
volume = "71",
pages = "88--90",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

T2 - Executive summary

AU - Floto, R. Andres

AU - Olivier, Kenneth N.

AU - Saiman, Lisa

AU - Daley, Charles L.

AU - Herrmann, Jean Louis

AU - Nick, Jerry A.

AU - Noone, Peadar G.

AU - Bilton, Diana

AU - Corris, Paul

AU - Gibson, Ronald L.

AU - Hempstead, Sarah E.

AU - Koetz, Karsten

AU - Sabadosa, Kathryn A.

AU - Sermet-Gaudelus, Isabelle

AU - Smyth, Alan R.

AU - Van Ingen, Jakko

AU - Wallace, Richard J.

AU - Winthrop, Kevin L.

AU - Marshall, Bruce

AU - Haworth, Charles S.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease, such as cystic fibrosis (CF). Pulmonary disease (PD) caused by NTM has emerged as a major threat to the health of individuals with CF, but remains difficult to diagnose and problematic to treat. In response to this challenge, the US Cystic Fibrosis Foundation (CFF) and the European Cystic Fibrosis Society (ECFS) convened a panel of 19 experts to develop consensus recommendations for the screening, investigation, diagnosis and management of NTM-PD in individuals with CF. PICO ( population, intervention, comparison, outcome) methodology and systematic literature reviews were employed to inform draft recommendations, which were then modified to achieve consensus and subsequently circulated for public consultation within the USA and European CF communities. We have thus generated a series of pragmatic, evidence-based recommendations as an initial step in optimising management for this challenging condition.

AB - Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease, such as cystic fibrosis (CF). Pulmonary disease (PD) caused by NTM has emerged as a major threat to the health of individuals with CF, but remains difficult to diagnose and problematic to treat. In response to this challenge, the US Cystic Fibrosis Foundation (CFF) and the European Cystic Fibrosis Society (ECFS) convened a panel of 19 experts to develop consensus recommendations for the screening, investigation, diagnosis and management of NTM-PD in individuals with CF. PICO ( population, intervention, comparison, outcome) methodology and systematic literature reviews were employed to inform draft recommendations, which were then modified to achieve consensus and subsequently circulated for public consultation within the USA and European CF communities. We have thus generated a series of pragmatic, evidence-based recommendations as an initial step in optimising management for this challenging condition.

UR - http://www.scopus.com/inward/record.url?scp=84958211439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958211439&partnerID=8YFLogxK

U2 - 10.1136/thoraxjnl-2015-207983

DO - 10.1136/thoraxjnl-2015-207983

M3 - Article

VL - 71

SP - 88

EP - 90

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 1

ER -